Anti-COVID property of subcutaneous ivermectin in synergy with zinc among midlife moderately symptomatic patients: a structured summary of a study protocol for a randomised controlled trial.
Ashraf S, Ashraf S, Farooq I, Ashraf S, Ashraf M, Imran MA, Kalsoom L, Akmal R, Ghufran M, Rafique S, Akram MK, Habib Z, Siddiqui UN, Ahmad A, Arshad S, Virk MAR, Gul M, Awais AB, Hassan M, Sherazi SSH, Safdar Z, Munir I, Khalid H, Munir K, Majeed N, Alahmadi YM, Humayun A, Saboor QA, Ahmad A, Ashraf M, Izhar M; DOCTORS LOUNGE Consortium.
.
. Pruitt RN, et al.Nature. 2021 Sep 8. doi: 10.1038/s41586-021-03829-0. Online ahead of print.Nature. 2021.PMID: 34497423
.Free PMC article.
. DeVito LM, et al.Ann N Y Acad Sci. 2021 Sep 8. doi: 10.1111/nyas.14681. Online ahead of print.Ann N Y Acad Sci. 2021.PMID: 34498278
.
![top](data:image/svg+xml,%3Csvg%20xmlns="http://www.w3.org/2000/svg"%20width="16"%20height="16"%3E%3Crect%20fill-opacity="0"/%3E%3C/svg%3E "top")